Jushi Holdings Posts Mixed Q2 2026 Results Amid Strategic Shifts — Jushi Holdings Inc.

Event summary

Revenue increased 10% year-over-year to $71.3 million, with wholesale revenue surging 68% to a record $9.4 million.
Virginia achieved record quarterly revenue ahead of adult-use sales launch on July 1, 2027.
Recognized a $6.4 million discrete income tax benefit from the federal rescheduling of medical marijuana.
Net loss narrowed to $7.3 million from $12.3 million in Q2 2025, with adjusted EBITDA margin at 18.7%.
Shareholders approved corporate continuance from British Columbia to Nevada.

The big picture

Jushi Holdings' Q2 2026 results reflect a strategic pivot towards wholesale growth and regulatory advantages. The company's focus on Virginia's impending adult-use market and operational efficiencies highlights its positioning in the evolving cannabis landscape. With $71.3 million in revenue and a narrowed net loss, Jushi is balancing short-term financial performance with long-term market expansion.

What we're watching

Regulatory Tailwinds: How the federal rescheduling of medical marijuana will impact Jushi's tax burden and operational flexibility.
Market Expansion: The pace at which Virginia's transition to adult-use cannabis will drive revenue growth starting July 2027.
Financial Strategy: Whether Jushi can sustain its adjusted EBITDA margin amid continued pricing pressure and promotional activity.